{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:52:12Z","timestamp":1787755932071,"version":"build-2784847793"},"reference-count":173,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transplant Infectious Dis"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:label\/>\n                    <jats:p>Over the past several decades there have been significant advances in nucleos(t)ide analogue (NA) antiviral therapy for hepatitis B virus (HBV) and global expansion of primary prevention through immunization. Despite this, HBV remains a leading cause of chronic liver disease globally, affecting over 250 million people. NA therapy has dramatically reduced the need for liver transplantation in HBV and transformed post\u2010transplant outcomes from historically poor to excellent. Similarly, the outcomes of kidney transplant recipients with HBV under NA therapy are now similar to those without HBV. Kidney and other non\u2010liver recipients, previously exposed to hepatitis B as demonstrated by a positive antibody to hepatitis B core antibody (anti\u2010HBc) while at risk for reactivation posttransplant have excellent outcomes when prevention strategies of either HBV monitoring or NA prophylaxis are utilized. The advances in HBV antiviral therapy have also led to increasing evidence that the organ donor pool can be expanded not only through the use of donors with positive anti\u2010HBc, but also those who are hepatitis B surface antigen (HBsAg) positive. In this review, we summarize the current state of the evidence regarding HBV amongst organ donors and recipients of liver and non\u2010liver organ transplants as well as the persisting gaps in evidence and opportunities for further research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/tid.70299","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:14:03Z","timestamp":1787753643000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis B in Organ Transplantation\u2014Current Evidence and Clinical Gaps"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1217-3756","authenticated-orcid":false,"given":"Oscar A.","family":"Fernandez\u2010Garcia","sequence":"first","affiliation":[{"name":"Universtiy of Alberta  Edmonton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1212-9826","authenticated-orcid":false,"given":"Britta L.","family":"Hirsch","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Epidemiology University Hospital of Zurich  Zurich Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5566-8628","authenticated-orcid":false,"given":"Irene A.","family":"Abela","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and Hospital Epidemiology University Hospital of Zurich  Zurich Switzerland"},{"name":"Institute of Medical Virology University of Zurich  Zurich Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1660-9166","authenticated-orcid":false,"given":"Karen E.","family":"Doucette","sequence":"additional","affiliation":[{"name":"Universtiy of Alberta  Edmonton Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"e_1_2_8_2_1","unstructured":"\u201cHepatitis B \u201dWHO published July 28 2026 https:\/\/www.who.int\/news\u2010room\/fact\u2010sheets\/detail\/hepatitis\u2010b."},{"issue":"2","key":"e_1_2_8_3_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2025.101938","article-title":"Chronic Hepatitis B Virus Persistence: Mechanisms, Consequences and Implications for Achieving Cure","volume":"30","author":"Georgi C.","year":"2025","journal-title":"Annals of Hepatology"},{"key":"e_1_2_8_4_1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jama.1965.03080070025007","article-title":"\u201cNew\u201d Antigen in Leukemia Sera","volume":"191","author":"Blumberg B. S.","year":"1965","journal-title":"Jama"},{"issue":"7649","key":"e_1_2_8_5_1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0140-6736(70)90926-8","article-title":"Virus\u2010Like Particles in Serum of Patients With Australia\u2010Antigen\u2010Associated Hepatitis","volume":"1","author":"Dane D. S.","year":"1970","journal-title":"Lancet"},{"issue":"6107","key":"e_1_2_8_6_1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/bmj.1.6107.216","article-title":"Familial HBsAg\u2010Positive Hepatoma: Treatment With Orthotopic Liver Transplantation and Specific Immunoglobulin","volume":"1","author":"Johnson P. J.","year":"1978","journal-title":"British Medical Journal"},{"issue":"3","key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"412","DOI":"10.7326\/0003-4819-91-3-412","article-title":"The Transplanted Kidney as a Source of Hepatitis B Infection","volume":"91","author":"Wolf J. L.","year":"1979","journal-title":"Annals of Internal Medicine"},{"key":"e_1_2_8_8_1","doi-asserted-by":"crossref","unstructured":"\u201cHealth Consensus Development Conference Statement: Liver2 Transplantation\u2014June 20\u201323 1983 \u201dHepatology4 no.1(1984):107S\u2013110S.","DOI":"10.1002\/hep.1840040725"},{"issue":"6647","key":"e_1_2_8_9_1","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/bmj.297.6647.522","article-title":"Renal Transplantation From HBsAg Positive Donors to HBsAg Negative Recipients","volume":"297","author":"Chan M. K.","year":"1988","journal-title":"BMJ"},{"key":"e_1_2_8_10_1","first-page":"2387","article-title":"Immunoprophylaxis of Hepatitis B Virus Reinfection in Recipients of Human Liver Allografts","volume":"19","author":"Lauchart W.","year":"1987","journal-title":"Transplantation Proceedings"},{"issue":"8745","key":"e_1_2_8_11_1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0140-6736(91)92515-4","article-title":"Passive Immunoprophylaxis After Liver Transplantation in HBsAg\u2010Positive Patients","volume":"337","author":"Samuel D.","year":"1991","journal-title":"Lancet"},{"issue":"3","key":"e_1_2_8_12_1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1089-3261(03)00045-X","article-title":"Hepatitis B Immune Globulin Preparations and Use in Liver Transplantation","volume":"7","author":"Terrault N. A.","year":"2003","journal-title":"Clinics in Liver Disease"},{"issue":"1","key":"e_1_2_8_13_1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/hep.1840130122","article-title":"Hepatic Histological Findings After Transplantation for Chronic Hepatitis B Virus Infection, Including a Unique Pattern of Fibrosing Cholestatic Hepatitis","volume":"13","author":"Davies S. E.","year":"1991","journal-title":"Hepatology"},{"issue":"6","key":"e_1_2_8_14_1","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1053\/jhep.2002.33681","article-title":"Increasing Applicability of Liver Transplantation for Patients With Hepatitis B\u2010Related Liver Disease","volume":"35","author":"Steinm\u00fcller T.","year":"2002","journal-title":"Hepatology"},{"issue":"2","key":"e_1_2_8_15_1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/jhep.2001.21554","article-title":"A Multicenter United States\u2010Canadian Trial to Assess Lamivudine Monotherapy Before and After Liver Transplantation for Chronic Hepatitis B","volume":"33","author":"Perrillo R. P.","year":"2001","journal-title":"Hepatology"},{"issue":"8","key":"e_1_2_8_16_1","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/lt.20471","article-title":"Transplantation of Hepatitis B Surface Antigen\u2010Positive Livers into Hepatitis B Virus\u2010Positive Recipients and the Role of Hepatitis Delta Coinfection","volume":"11","author":"Franchello A.","year":"2005","journal-title":"Liver Transplantation"},{"issue":"10","key":"e_1_2_8_17_1","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1016\/j.transproceed.2005.10.094","article-title":"The Effect of HBsAg\u2010Positivity of Kidney Donors on Long\u2010Term Patient and Graft Outcome","volume":"37","author":"Berber I.","year":"2005","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"e_1_2_8_18_1","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/lt.20799","article-title":"Five\u2010Year Follow\u2010Up of a Hepatitis B Virus\u2010Positive Recipient of Hepatitis B Surface Antigen\u2010Positive Living Donor Liver Graft","volume":"12","author":"Hwang S.","year":"2006","journal-title":"Liver Transplantation"},{"issue":"9","key":"e_1_2_8_19_1","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1478-3231.2007.01528.x","article-title":"Successful Living Donor Liver Transplantation Using a Graft From a Hepatitis B Surface Antigen\u2010Positive Donor","volume":"27","author":"Soejima Y.","year":"2007","journal-title":"Liver International"},{"issue":"35","key":"e_1_2_8_20_1","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.3748\/wjg.v22.i35.8010","article-title":"Liver Grafts From Hepatitis B Surface Antigen\u2010Positive Donors: A Review of the Literature","volume":"22","author":"Loggi E.","year":"2016","journal-title":"World Journal of Gastroenterology"},{"issue":"4","key":"e_1_2_8_21_1","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1053\/j.gastro.2011.06.083","article-title":"Entecavir Monotherapy Is Effective in Suppressing Hepatitis B Virus After Liver Transplantation","volume":"141","author":"Fung J.","year":"2011","journal-title":"Gastroenterology"},{"issue":"3","key":"e_1_2_8_22_1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jhep.2011.09.016","article-title":"Liver Transplantation From Hepatitis B Surface Antigen Positive Donors: A Safe Way to Expand the Donor Pool","volume":"56","author":"Loggi E.","year":"2012","journal-title":"Journal of Hepatology"},{"issue":"5","key":"e_1_2_8_23_1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/tid.12434","article-title":"Tenofovir\/Entecavir Monotherapy After Hepatitis B Immunoglobulin Withdrawal is Safe and Effective in the Prevention of Hepatitis B in Liver Transplant Recipients","volume":"17","author":"Fern\u00e1ndez I.","year":"2015","journal-title":"Transplant Infectious Disease: An Official Journal of the Transplantation Society"},{"issue":"12","key":"e_1_2_8_24_1","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00535-013-0761-x","article-title":"Post\u2010Transplantation Sequential Entecavir Monotherapy Following 1\u2010Year Combination Therapy With Hepatitis B Immunoglobulin","volume":"48","author":"Yi N. J.","year":"2013","journal-title":"Journal of Gastroenterology"},{"issue":"8","key":"e_1_2_8_25_1","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1111\/ajt.15886","article-title":"Hepatitis B Surface Antigen\u2010Positive Donor to Negative Recipient Lung Transplantation","volume":"20","author":"Belga S.","year":"2020","journal-title":"American Journal of Transplantation"},{"issue":"9","key":"e_1_2_8_26_1","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13514","article-title":"Viral Hepatitis: Guidelines by the American Society of Transplantation Infectious Disease Community of Practice","volume":"33","author":"Te H.","year":"2019","journal-title":"Clinical Transplantation"},{"issue":"2","key":"e_1_2_8_27_1","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","article-title":"EASL Clinical Practice Guidelines on the Management of Hepatitis B Virus Infection","volume":"83","author":"Cornberg M.","year":"2025","journal-title":"Journal of Hepatology"},{"issue":"4","key":"e_1_2_8_28_1","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/HEP.0000000000001549","article-title":"AASLD ISDA Practice Guideline on Treatment of Chronic Hepatitis B","volume":"83","author":"Ghany M. G.","year":"2026","journal-title":"Hepatology"},{"issue":"1","key":"e_1_2_8_29_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/cld.728","article-title":"Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance","volume":"12","author":"Terrault N. A.","year":"2018","journal-title":"Clinical Liver Disease"},{"issue":"5","key":"e_1_2_8_30_1","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/ajt.13187","article-title":"Solid Organ Transplantation From Hepatitis B Virus\u2010Positive Donors: Consensus Guidelines for Recipient Management","volume":"15","author":"Huprikar S.","year":"2015","journal-title":"American Journal of Transplantation"},{"issue":"7","key":"e_1_2_8_31_1","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.70236","article-title":"Hepatitis B Virus NAT Positive Donors in Non\u2010Hepatic Organ Transplant: Quantifying Viral Loads to Optimize Recipient Risk Stratification and Management in the Prevention of Donor\u2010Derived Infection","volume":"39","author":"Tam P. C. K.","year":"2025","journal-title":"Clinical Transplantation"},{"issue":"12","key":"e_1_2_8_32_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-046293","article-title":"Efficacy and Safety of Stratified Versus Routine Prophylaxis in Living Kidney Transplantation From HBsAg+ Donors to HBsAg\u2212 Recipients: Protocol for a Multicentre, Prospective, Observational Study","volume":"11","author":"Wang X.","year":"2021","journal-title":"BMJ Open"},{"issue":"4","key":"e_1_2_8_33_1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1053\/jlts.2001.23069","article-title":"Double\u2010Dose Accelerated Hepatitis B Vaccine in Patients with End\u2010Stage Liver Disease","volume":"7","author":"Arslan M.","year":"2001","journal-title":"Liver Transplantation"},{"issue":"2","key":"e_1_2_8_34_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056974","article-title":"Serologic Vaccination Response after Solid Organ Transplantation: A Systematic Review","volume":"8","author":"Eckerle I.","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"e_1_2_8_35_1","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3390\/cells9061486","article-title":"Hepatitis B Virus Entry Into Cells","volume":"9","author":"Herrscher C.","year":"2020","journal-title":"Cells"},{"issue":"5","key":"e_1_2_8_36_1","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01686-21","article-title":"Establishment of a Monoclonal Antibody against Human NTCP That Blocks Hepatitis B Virus Infection","volume":"96","author":"Takemori T.","year":"2022","journal-title":"Journal of Virology"},{"issue":"3","key":"e_1_2_8_37_1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/hep.23778","article-title":"Novel Mechanism of Antibodies to Hepatitis B Virus in Blocking Viral Particle Release From Cells","volume":"52","author":"Neumann A. U.","year":"2010","journal-title":"Hepatology"},{"issue":"6","key":"e_1_2_8_38_1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jhep.2024.06.037","article-title":"Hepatitis B Virus DNA Integration: Implications for Diagnostics, Therapy, and Outcome","volume":"81","author":"Zoulim F.","year":"2024","journal-title":"Journal of Hepatology"},{"issue":"5","key":"e_1_2_8_39_1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2217\/fvl-2019-0147","article-title":"The Role of Hepatitis B Surface Antibodies in Hbv Infection, Disease and Clearance","volume":"15","author":"Warner N.","year":"2020","journal-title":"Future Virology"},{"issue":"1","key":"e_1_2_8_40_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices","volume":"67","author":"Schillie S.","year":"2018","journal-title":"MMWR Recommendations and Reports"},{"issue":"10","key":"e_1_2_8_41_1","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/lt.24814","article-title":"Active Immunization for Prevention of De Novo Hepatitis B Virus Infection After Adult Living Donor Liver Transplantation With a Hepatitis B Core Antigen\u2013Positive Graft","volume":"23","author":"Wang S. H.","year":"2017","journal-title":"Liver Transplantation"},{"issue":"7","key":"e_1_2_8_42_1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1478-3231.2007.01521.x","article-title":"Hepatitis B Vaccination After Living Donor Liver Transplantation","volume":"27","author":"Soejima Y.","year":"2007","journal-title":"Liver International"},{"issue":"39","key":"e_1_2_8_43_1","doi-asserted-by":"crossref","first-page":"11112","DOI":"10.3748\/wjg.v21.i39.11112","article-title":"Active Vaccination to Prevent De Novo Hepatitis B Virus Infection in Liver Transplantation","volume":"21","author":"Lin C. C.","year":"2015","journal-title":"World Journal of Gastroenterology"},{"key":"e_1_2_8_44_1","first-page":"1097","article-title":"HepB\u2010CpG Vaccination: An Alternate Strategy to Life Long Antiviral Therapy in Patients Transplanted for Chronic Hepatitis B","volume":"10","author":"Garrido\u2010Trevino L.","year":"2025","journal-title":"Liver Transplantation"},{"issue":"1","key":"e_1_2_8_45_1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12985-022-01946-4","article-title":"Reactivation of Occult Hepatitis B Virus Infection in a Renal Transplant Recipient","volume":"19","author":"Jiang L.","year":"2022","journal-title":"Virology Journal"},{"issue":"6","key":"e_1_2_8_46_1","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/cid\/ciaa178","article-title":"Kidney Transplantation From Hepatitis B Surface Antigen (HBsAg)\u2010Positive Living Donors to HBsAg\u2010Negative Recipients: Clinical Outcomes at a High\u2010Volume Center in China","volume":"72","author":"Wang X. D.","year":"2021","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"e_1_2_8_47_1","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13872","article-title":"Use of Hepatitis B Viremic Donors in Kidney Transplant Recipients: A Single Center Experience","volume":"24","author":"Carnemolla B. T.","year":"2022","journal-title":"Transplant Infectious Disease: An Official Journal of the Transplantation Society"},{"issue":"4","key":"e_1_2_8_48_1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1053\/jlts.2000.8313","article-title":"Vaccination Against Hepatitis B Virus in Cirrhotic Patients on Liver Transplant Waiting List","volume":"6","author":"Dom\u00ednguez M.","year":"2000","journal-title":"Liver Transplantation"},{"issue":"1","key":"e_1_2_8_49_1","article-title":"Reestablishment of Active Immunity Against HBV Graft Reinfection after Liver Transplantation for HBV\u2010Related End Stage Liver Disease","volume":"2014","author":"Lu S.\u2010C.","year":"2014","journal-title":"Journal of Immunology Research"},{"issue":"3","key":"e_1_2_8_50_1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00535-010-0313-6","article-title":"Different Effect of HBV Vaccine After Liver Transplantation Between Chronic HBV Carriers and Non\u2010HBV Patients who Received HBcAb\u2010Positive Grafts","volume":"46","author":"Ishigami M.","year":"2011","journal-title":"Journal of Gastroenterology"},{"issue":"10","key":"e_1_2_8_51_1","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1016\/j.transproceed.2021.09.038","article-title":"Efficacy and Safety of Hepatitis B Virus Vaccination Following Hepatitis B Immunoglobulin Withdrawal After Liver Transplantation","volume":"53","author":"Jo H.\u2010S.","year":"2021","journal-title":"Transplantation Proceedings"},{"issue":"2","key":"e_1_2_8_52_1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.clinre.2019.08.007","article-title":"Vaccination in Adult Liver Transplantation Candidates and Recipients","volume":"44","author":"Valour F.","year":"2020","journal-title":"Clinics and Research in Hepatology and Gastroenterology"},{"issue":"9","key":"e_1_2_8_53_1","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15464","article-title":"Hepatitis B Vaccine Compliance, Serologic Response, and Durability in Adult Thoracic Organ Transplant Recipients","volume":"38","author":"Chiu C. Y.","year":"2024","journal-title":"Clinical Transplantation"},{"issue":"2","key":"e_1_2_8_54_1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/ndt\/gfac039","article-title":"A Real World Comparison of HepB (Engerix\u2010B(R)) and HepB\u2010CpG (Heplisav\u2010B(R)) Vaccine Seroprotection in Patients Receiving Maintenance Dialysis","volume":"38","author":"Manley H. J.","year":"2023","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"4","key":"e_1_2_8_55_1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1590\/S1413-86702008000400009","article-title":"Double\u2010Dose Hepatitis B Vaccination in Cirrhotic Patients on a Liver Transplant Waiting List","volume":"12","author":"Bonazzi P. R.","year":"2008","journal-title":"Brazilian Journal of Infectious Diseases"},{"issue":"1","key":"e_1_2_8_56_1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11894-012-0300-6","article-title":"Immunizations in Chronic Liver Disease: What Should be Done and What is the Evidence","volume":"15","author":"Leise M. D.","year":"2013","journal-title":"Current Gastroenterology Reports"},{"issue":"4","key":"e_1_2_8_57_1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1586\/erv.10.162","article-title":"Hepatitis B Surface Antigen\u20101018 ISS Adjuvant\u2010Containing Vaccine: A Review of HEPLISAV\u2122 Safety and Efficacy","volume":"10","author":"Cooper C.","year":"2011","journal-title":"Expert Review of Vaccines"},{"issue":"15","key":"e_1_2_8_58_1","doi-asserted-by":"crossref","first-page":"455","DOI":"10.15585\/mmwr.mm6715a5","article-title":"Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine With a Novel Adjuvant","volume":"67","author":"Schillie S.","year":"2018","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"5","key":"e_1_2_8_59_1","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.vaccine.2017.12.038","article-title":"Immunogenicity of a Two\u2010Dose Investigational Hepatitis B Vaccine, HBsAg\u20101018, Using a Toll\u2010Like Receptor 9 Agonist Adjuvant Compared with a Licensed Hepatitis B Vaccine in Adults","volume":"36","author":"Jackson S.","year":"2018","journal-title":"Vaccine"},{"key":"e_1_2_8_60_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126705","article-title":"Optimizing Hepatitis B Virus Seroprotection in Thoracic Organ Transplantation: The Role of HepB\u2010CpG (Heplisav\u2010B) Vaccination Schedule","volume":"47","author":"Chiu C. Y.","year":"2025","journal-title":"Vaccine"},{"issue":"4","key":"e_1_2_8_61_1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1001\/jama.2024.24490","article-title":"HepB\u2010CpG vs HepB\u2010Alum Vaccine in People With HIV and Prior Vaccine Nonresponse: The BEe\u2010HIVe Randomized Clinical Trial","volume":"333","author":"Marks K. M.","year":"2025","journal-title":"Jama"},{"issue":"3","key":"e_1_2_8_62_1","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/cid\/ciad201","article-title":"Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll\u2010Like Receptor 9 Agonist Adjuvant in HBV Vaccine\u2010Naive People With Human Immunodeficiency Virus","volume":"77","author":"Marks K. M.","year":"2023","journal-title":"Clinical Infectious Diseases"},{"issue":"31","key":"e_1_2_8_63_1","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1016\/j.vaccine.2023.06.041","article-title":"Vaccination with HepB\u2010CpG Vaccine in Individuals Undergoing Immune Suppressive Drug Therapy","volume":"41","author":"Perrillo R.","year":"2023","journal-title":"Vaccine"},{"issue":"20","key":"e_1_2_8_64_1","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1016\/j.vaccine.2023.04.028","article-title":"Long\u2010Term Immunogenicity and Safety of the Hepatitis B Vaccine HepB\u2010CpG (HEPLISAV\u2010B) Compared With HepB\u2010Eng (Engerix\u2010B) in Adults with Chronic Kidney Disease","volume":"41","author":"Girndt M.","year":"2023","journal-title":"Vaccine"},{"issue":"12","key":"e_1_2_8_65_1","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/lt.24218","article-title":"Outcomes Including Liver Histology After Liver Transplantation for Chronic Hepatitis B Using Oral Antiviral Therapy Alone","volume":"21","author":"Fung J.","year":"2015","journal-title":"Liver Transplantation"},{"issue":"4","key":"e_1_2_8_66_1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/lt.20402","article-title":"Viral Load at the Time of Liver Transplantation and Risk of Hepatitis B Virus Recurrence","volume":"11","author":"Marzano A.","year":"2005","journal-title":"Liver Transplantation"},{"issue":"48","key":"e_1_2_8_67_1","doi-asserted-by":"crossref","first-page":"9189","DOI":"10.3748\/wjg.v19.i48.9189","article-title":"Review of the Pharmacological Management of Hepatitis B Viral Infection Before and After Liver Transplantation","volume":"19","author":"Cholongitas E.","year":"2013","journal-title":"World Journal of Gastroenterology: WJG"},{"issue":"3","key":"e_1_2_8_68_1","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13522","article-title":"Safety and Efficacy of Tenofovir Alafenamide in Liver Transplant Recipients: A Single Center Experience","volume":"23","author":"Rashidi\u2010Alavijeh J.","year":"2021","journal-title":"Transplant Infectious Disease"},{"issue":"5","key":"e_1_2_8_69_1","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3390\/v15051037","article-title":"The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation","volume":"15","author":"Battistella S.","year":"2023","journal-title":"Viruses"},{"issue":"7","key":"e_1_2_8_70_1","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.ajt.2025.03.003","article-title":"Liver Transplantation for Hepatitis D Virus\/Hepatitis B Virus Coinfection in Italy: An Intention\u2010to\u2010Treat Analysis of Long\u2010Term Outcomes","volume":"25","author":"Angelico R.","year":"2025","journal-title":"American Journal of Transplantation"},{"key":"e_1_2_8_71_1","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1007\/s10620-025-09654-z","article-title":"Long\u2010Term Post\u2010Transplant Outcomes in Patients with Hepatitis D Virus Infection at a High\u2010Volume Liver Transplant Center","volume":"71","author":"Keser M. F.","year":"2026","journal-title":"Digestive Diseases and Sciences"},{"issue":"4","key":"e_1_2_8_72_1","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/hep.29191","article-title":"Long\u2010Term Outcomes of Entecavir Monotherapy for Chronic Hepatitis B After Liver Transplantation: Results up to 8 Years","volume":"66","author":"Fung J.","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"e_1_2_8_73_1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3390\/v17040454","article-title":"Chronic Hepatitis B in the Transplant Setting: A 30\u2010Year Experience in a Single Tertiary Italian Center","volume":"17","author":"Russo F. P.","year":"2025","journal-title":"Viruses"},{"issue":"6","key":"e_1_2_8_74_1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/lt.23628","article-title":"Randomized Trial of Emtricitabine\/Tenofovir Disoproxil Fumarate After Hepatitis B Immunoglobulin Withdrawal After Liver Transplantation","volume":"19","author":"Teperman L. W.","year":"2013","journal-title":"Liver Transplantation"},{"issue":"9","key":"e_1_2_8_75_1","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1097\/TP.0000000000001786","article-title":"Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients","volume":"101","author":"Radhakrishnan K.","year":"2017","journal-title":"Transplantation"},{"issue":"9","key":"e_1_2_8_76_1","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.dld.2018.03.032","article-title":"Entecavir or Tenofovir Monotherapy Prevents HBV Recurrence in Liver Transplant Recipients: A 5\u2010Year Follow\u2010Up Study After Hepatitis B Immunoglobulin Withdrawal","volume":"50","author":"Manini M. A.","year":"2018","journal-title":"Digestive and Liver Disease"},{"key":"e_1_2_8_77_1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12072-019-10011-2","article-title":"Nucleoside Analog Monotherapy for Prophylaxis in Hepatitis B Liver Transplant Patients is Safe and Efficacious","volume":"14","author":"Muthiah M.","year":"2020","journal-title":"Hepatology International"},{"issue":"1","key":"e_1_2_8_78_1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.transproceed.2020.04.1822","article-title":"A Very Short Course of HBIg+NA Followed by Entecavir or Tenofovir Monotherapy Prevents HBV Recurrence in Low\u2010Risk Liver Transplant Recipients","volume":"53","author":"Manini M. A.","year":"2021","journal-title":"Transplantation Proceedings"},{"key":"e_1_2_8_79_1","article-title":"The UK Experience with Hepatitis B Immunoglobulin use Following Liver Transplantation: Wide Variation in Practice Despite Evidence Supporting Cost\u2010Effective HBIG\u2010Free Prophylaxis","author":"Mohamed A.","journal-title":"Gut"},{"issue":"3","key":"e_1_2_8_80_1","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/LVT.0000000000000715","article-title":"AASLD AST Practice Guideline on Adult Liver Transplantation: Diagnosis and Management of Graft\u2010Related Complications","volume":"32","author":"Te H. S.","year":"2026","journal-title":"Liver Transplantation"},{"issue":"9","key":"e_1_2_8_81_1","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1097\/TP.0000000000005027","article-title":"Efficacy of Newer Nucleos(t)ide Analogs After Hepatitis B Immunoglobulin Discontinuation Against Hepatitis B and D Recurrence in Liver Transplant Recipients","volume":"108","author":"Cholongitas E.","year":"2024","journal-title":"Transplantation"},{"issue":"3","key":"e_1_2_8_82_1","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70033","article-title":"Bulevirtide in Chronic Hepatitis D Patients Awaiting Liver Transplantation Results From a French Multicentric Retrospective Study","volume":"45","author":"Meszaros M.","year":"2025","journal-title":"Liver International"},{"issue":"5","key":"e_1_2_8_83_1","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1600-6143.2010.03070.x","article-title":"HBV and HIV Coinfection and Liver Transplant","volume":"10","author":"Coffin C.","year":"2010","journal-title":"American Journal of Transplantation"},{"issue":"2","key":"e_1_2_8_84_1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jcv.2013.02.004","article-title":"Virology and Clinical Sequelae of Long\u2010Term Antiviral Therapy in a North American Cohort of Hepatitis B Virus (HBV)\/Human Immunodeficiency Virus Type 1 (HIV\u20101) Co\u2010Infected Patients","volume":"57","author":"Coffin C. S.","year":"2013","journal-title":"Journal of Clinical Virology"},{"issue":"1","key":"e_1_2_8_85_1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12879-024-09284-2","article-title":"Clinical Outcomes of Liver Transplantation in Human Immunodeficiency Virus\/Hepatitis B Virus Coinfected Patients in China","volume":"24","author":"Tang J.","year":"2024","journal-title":"BMC Infectious Diseases"},{"issue":"10","key":"e_1_2_8_86_1","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/lt.23935","article-title":"Frequent Incidence of Escape Mutants After Successful Hepatitis B Vaccine Response and Stopping of Nucleos(t)ide Analogues in Liver Transplant Recipients","volume":"20","author":"Ishigami M.","year":"2014","journal-title":"Liver Transplantation"},{"issue":"2","key":"e_1_2_8_87_1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/hep.510310233","article-title":"Hepatitis B Immunoglobulin Discontinuation Followed by Hepatitis B Virus Vaccination: A New Strategy in the Prophylaxis of Hepatitis B Virus Recurrence After Liver Transplantation","volume":"31","author":"S\u00e1nchez\u2010Fueyo A.","year":"2000","journal-title":"Hepatology"},{"issue":"1","key":"e_1_2_8_88_1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1053\/jhep.2002.30278","article-title":"Failure of a Reinforced Triple Course of Hepatitis B Vaccination in Patients Transplanted for HBV\u2010Related Cirrhosis","volume":"35","author":"Angelico M.","year":"2002","journal-title":"Hepatology"},{"issue":"1","key":"e_1_2_8_89_1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/jvh.13164","article-title":"Long\u2010Term Consequences of Stopping HBIG and\/or Nucleotide Analogues in Liver Transplant Recipients Administered Hepatitis B Vaccination to Prevent HBV Reinfection","volume":"26","author":"Duan B.\u2010W.","year":"2019","journal-title":"Journal of Viral Hepatitis"},{"issue":"3","key":"e_1_2_8_90_1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/lt.21003","article-title":"Failure of Hepatitis B Vaccination with Conventional HBsAg Vaccine in Patients with Continuous HBIG Prophylaxis After Liver Transplantation","volume":"13","author":"Rosenau J.","year":"2007","journal-title":"Liver Transplantation"},{"issue":"1","key":"e_1_2_8_91_1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0016-5085(88)90623-3","article-title":"Hepatitis B Virus and Hepatitis B\u2010Related Viral Infection in Renal Transplant Recipients. A Prospective Study of 90 Patients","volume":"94","author":"Degos F.","year":"1988","journal-title":"Gastroenterology"},{"issue":"5","key":"e_1_2_8_92_1","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/0016-5085(91)70034-U","article-title":"Redevelopment of Hepatitis B Surface Antigen After Renal Transplantation","volume":"100","author":"Marcellin P.","year":"1991","journal-title":"Gastroenterology"},{"issue":"2","key":"e_1_2_8_93_1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","article-title":"Update of the Statements on Biology and Clinical Impact of Occult Hepatitis B Virus Infection","volume":"71","author":"Raimondo G.","year":"2019","journal-title":"Journal of Hepatology"},{"issue":"3","key":"e_1_2_8_94_1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/TP.0b013e3181e5b811","article-title":"Long\u2010Term Outcome of Renal Transplant Recipients with Chronic Hepatitis B Infection\u2010Impact Of Antiviral Treatments","volume":"90","author":"Yap D. Y.","year":"2010","journal-title":"Transplantation"},{"issue":"4","key":"e_1_2_8_95_1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jcv.2004.07.001","article-title":"Effects of Long\u2010Term Lamivudine Therapy in Renal\u2010Transplant Patients","volume":"31","author":"Kamar N.","year":"2004","journal-title":"Journal of Clinical Virology"},{"issue":"10","key":"e_1_2_8_96_1","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1097\/00007890-200005270-00020","article-title":"HBV Genotypic Resistance to Lamivudine in Kidney Recipients and Hemodialyzed Patients","volume":"69","author":"Fontaine H.","year":"2000","journal-title":"Transplantation"},{"issue":"5","key":"e_1_2_8_97_1","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2018.12.036","article-title":"Control of Replication of Hepatitis B and C Virus Improves Patient and Graft Survival in Kidney Transplantation","volume":"70","author":"Fontaine H.","year":"2019","journal-title":"Journal of Hepatology"},{"issue":"1","key":"e_1_2_8_98_1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jhep.2012.02.020","article-title":"Benefits Associated With Antiviral Treatment in Kidney Allograft Recipients With Chronic Hepatitis B Virus Infection","volume":"57","author":"Cosconea S.","year":"2012","journal-title":"Journal of Hepatology"},{"issue":"5","key":"e_1_2_8_99_1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5414\/CN107565","article-title":"Long\u2010Term Outcome of Hepatitis B\u2010Positive Renal Allograft Recipients After Development of Antiviral Treatment","volume":"78","author":"Park K. S.","year":"2012","journal-title":"Clinical Nephrology"},{"issue":"3","key":"e_1_2_8_100_1","first-page":"S36","article-title":"The Effect of Hepatitis B Virus on Graft and Overall Survival in Kidney Transplant Patients","volume":"13","author":"Harmanc\u0131 \u00d6.","year":"2015","journal-title":"Experimental and Clinical Transplantation: Official Journal of the Middle East Society for Organ Transplantation"},{"issue":"2","key":"e_1_2_8_101_1","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.transproceed.2013.11.041","article-title":"Outcomes of Kidney Transplantation Recipients With Hepatitis in the Antiviral Therapy Era: A Single\u2010Center Experience","volume":"46","author":"Lu K.","year":"2014","journal-title":"Transplantation Proceedings"},{"issue":"8","key":"e_1_2_8_102_1","doi-asserted-by":"crossref","first-page":"P865","DOI":"10.1016\/S1053-2498(01)00280-7","article-title":"Hepatitis B Virus Infection in Heart Transplant Recipients in a Hepatitis B Endemic Area","volume":"20","author":"Ko W.","year":"2001","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"7","key":"e_1_2_8_103_1","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/j.transproceed.2006.06.011","article-title":"Successful Treatment of Hepatitis B Virus Infection With Lamivudine After Heart Transplantation","volume":"38","author":"Wang S. S.","year":"2006","journal-title":"Transplantation Proceedings"},{"issue":"8","key":"e_1_2_8_104_1","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1053-2498(01)00280-7","article-title":"Hepatitis B Virus Infection in Heart Transplant Recipients in a Hepatitis B Endemic Area","volume":"20","author":"Ko W. J.","year":"2001","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"e_1_2_8_105_1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.12659\/AOT.889680","article-title":"The Impact of Hepatitis B on Heart Transplantation: 19 Years of National Experience in Korea","volume":"19","author":"Shin H. S.","year":"2014","journal-title":"Annals of Transplantation"},{"issue":"4","key":"e_1_2_8_106_1","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.transproceed.2012.03.040","article-title":"Twenty\u2010Four Year Single\u2010Center Experience of Hepatitis B Virus Infection in Heart Transplantation","volume":"44","author":"Chen Y. C.","year":"2012","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"e_1_2_8_107_1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.healun.2003.09.036","article-title":"Acceptable Recipient Outcomes With the Use of Hearts From Donors with Hepatitis\u2010B Core Antibodies","volume":"24","author":"Pinney S. P.","year":"2005","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"8","key":"e_1_2_8_108_1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1053-2498(00)00142-X","article-title":"Outcomes in Patients Who are Hepatitis B Surface Antigen\u2010Positive Before Transplantation: An Analysis and Study Using the Joint ISHLT\/UNOS Thoracic Registry","volume":"19","author":"Hosenpud J. D.","year":"2000","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"47","key":"e_1_2_8_109_1","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000031962","article-title":"Resolved Hepatitis B Infection in Patients Receiving Immunosuppressive Therapy: Monitor Versus Prophylaxis Against Viral Reactivation","volume":"101","author":"Elsebaey M. A.","year":"2022","journal-title":"Medicine"},{"issue":"3","key":"e_1_2_8_110_1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep.24528","article-title":"Occult Hepatitis B Virus Infection: Bit Player or Role Player?","volume":"54","author":"Shire A. M.","year":"2011","journal-title":"Hepatology"},{"issue":"7","key":"e_1_2_8_111_1","first-page":"S114","article-title":"Occult Hepatitis B Virus Infection: Diagnosis, Implications and Management?","volume":"19","author":"Lok A. S.","year":"2004","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"2","key":"e_1_2_8_112_1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2468-1253(16)30076-0","article-title":"Significance of Anti\u2010HBc Alone Serological Status in Clinical Practice","volume":"2","author":"Wang Q.","year":"2017","journal-title":"Lancet Gastroenterology & Hepatology"},{"issue":"7","key":"e_1_2_8_113_1","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/liv.14860","article-title":"Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation: Current Concepts","volume":"41","author":"Orfanidou A.","year":"2021","journal-title":"Liver International"},{"issue":"3","key":"e_1_2_8_114_1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0168-8278(97)80416-3","article-title":"De Novo and Apparent De Novo Hepatitis B Virus Infection After Liver Transplantation","volume":"26","author":"Roche B.","year":"1997","journal-title":"Journal of Hepatology"},{"issue":"3","key":"e_1_2_8_115_1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/00007890-200202150-00027","article-title":"Failure of Reactivation of Hepatitis B After Liver Transplantation in Hepatitis B Surface Antigen\u2010Negative, Core Antibody\u2010Positive Recipients","volume":"73","author":"Maguire D.","year":"2002","journal-title":"Transplantation"},{"issue":"3","key":"e_1_2_8_116_1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1034\/j.1399-3062.2003.00021.x","article-title":"Retrospective Evaluation of the Risk of Hepatitis B Virus Reactivation After Transplantation","volume":"5","author":"Duhart B. T.","year":"2003","journal-title":"Transplant Infectious Disease: An Official Journal of the Transplantation Society"},{"issue":"12","key":"e_1_2_8_117_1","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.hs.2003.09.013","article-title":"Subclinical Reactivation of Hepatitis B Virus in Liver Transplant Recipients With Past Exposure","volume":"9","author":"Abdelmalek M. F.","year":"2003","journal-title":"Liver Transplantation"},{"issue":"3","key":"e_1_2_8_118_1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/liv.12567","article-title":"Occult Hepatitis B Virus Infection Predicts De Novo Hepatitis B Infection in Patients With Alcoholic Cirrhosis After Liver Transplantation","volume":"35","author":"Xie M.","year":"2015","journal-title":"Liver International"},{"issue":"3","key":"e_1_2_8_119_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004196","article-title":"Incidence, Risk Factors, and Clinical Outcomes of HBV Reactivation in Non\u2010Liver Solid Organ Transplant Recipients With Resolved HBV Infection: A Systematic Review and Meta\u2010Analysis","volume":"20","author":"Yin S.","year":"2023","journal-title":"PLoS Medicine"},{"issue":"7","key":"e_1_2_8_120_1","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15389","article-title":"Hepatitis B Virus Reactivation in Non\u2010Liver Solid Organ Transplantation: Incidence and Risk Analysis","volume":"38","author":"Chiu C. Y.","year":"2024","journal-title":"Clinical Transplantation"},{"issue":"6","key":"e_1_2_8_121_1","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1053\/j.gastro.2017.02.009","article-title":"Hepatitis B reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions","volume":"152","author":"Loomba R.","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"e_1_2_8_122_1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1093\/ndt\/gfw455","article-title":"Rituximab and Hepatitis B Reactivation in HBsAg\u2010Negative\/Anti\u2010HBc\u2010Positive Kidney Transplant Recipients","volume":"32","author":"Lee J.","year":"2017","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"3","key":"e_1_2_8_123_1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/tid.12065","article-title":"Outcomes and Risk Factors for Hepatitis B Virus (HBV) Reactivation After Kidney Transplantation in Occult HBV Carriers","volume":"15","author":"Chen G. D.","year":"2013","journal-title":"Transplant Infectious Disease"},{"issue":"7","key":"e_1_2_8_124_1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/jvh.13279","article-title":"Hepatitis B Reactivation After Kidney Transplantation in Hepatitis B Surface Antigen\u2010Negative, Core Antibody\u2010Positive Recipients","volume":"27","author":"Kim J.","year":"2020","journal-title":"Journal of Viral Hepatitis"},{"issue":"2","key":"e_1_2_8_125_1","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13234","article-title":"Hepatitis B Virus Reactivation in Kidney Transplant Patients With Resolved Hepatitis B Virus Infection: Risk Factors and the Safety and Efficacy of Preemptive Therapy","volume":"22","author":"Mei T.","year":"2020","journal-title":"Transplant Infectious Disease"},{"key":"e_1_2_8_126_1","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11122","article-title":"Risk Stratification for Hepatitis b Virus Reactivation in Kidney Transplant Recipients With Resolved HBV Infection","volume":"36","author":"Tsai H.\u2010J.","year":"2023","journal-title":"Transplant International"},{"issue":"10","key":"e_1_2_8_127_1","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1097\/TP.0000000000002173","article-title":"Presence of Hepatitis B Surface Antibody in Addition to Hepatitis B Core Antibody Confers Protection Against Hepatitis B Virus Infection in Hepatitis B Surface Antigen\u2013Negative Patients Undergoing Kidney Transplantation","volume":"102","author":"Jeon J. W.","year":"2018","journal-title":"Transplantation"},{"issue":"3","key":"e_1_2_8_128_1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jcv.2012.07.015","article-title":"Significant Rate of Hepatitis B Reactivation Following Kidney Transplantation in Patients With Resolved Infection","volume":"55","author":"Kanaan N.","year":"2012","journal-title":"Journal of Clinical Virology"},{"key":"e_1_2_8_129_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhlto.2023.100018","article-title":"Hepatitis B Virus Reactivation in Hepatitis B Core Antibody Positive Lung Transplant Recipients","volume":"3","author":"Fernandez\u2010Garcia O. A.","year":"2024","journal-title":"JHLT Open"},{"issue":"6","key":"e_1_2_8_130_1","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1128\/jvi.69.6.3350-3357.1995","article-title":"The Covalently Closed Duplex Form of the Hepadnavirus Genome Exists In Situ as a Heterogeneous Population of Viral Minichromosomes","volume":"69","author":"Newbold J. E.","year":"1995","journal-title":"Journal of Virology"},{"issue":"5","key":"e_1_2_8_131_1","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1053\/gast.1997.v113.pm9352871","article-title":"Transmission of Hepatitis B by Transplantation of Livers From Donors Positive for Antibody to Hepatitis B Core Antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database","volume":"113","author":"Dickson R. C.","year":"1997","journal-title":"Gastroenterology"},{"issue":"11","key":"e_1_2_8_132_1","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1097\/00007890-199712150-00013","article-title":"Infectivity of Hepatic Allografts With Antibodies to Hepatitis B Virus","volume":"64","author":"Dodson S. F.","year":"1997","journal-title":"Transplantation"},{"issue":"1","key":"e_1_2_8_133_1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/jlts.2001.20786","article-title":"De Novo Hepatitis B After Liver Transplantation From Hepatitis B Core Antibody\u2010Positive Donors in an Area With High Prevalence of Anti\u2010HBc Positivity in the Donor Population","volume":"7","author":"Prieto M.","year":"2001","journal-title":"Liver Transplantation"},{"issue":"6","key":"e_1_2_8_134_1","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jhep.2019.03.003","article-title":"Liver Transplantation Using Hepatitis B Core Positive Grafts With Antiviral Monotherapy Prophylaxis","volume":"70","author":"Wong T. C.","year":"2019","journal-title":"Journal of Hepatology"},{"issue":"2","key":"e_1_2_8_135_1","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15263","article-title":"De Novo Hepatitis B Infection Following Liver Transplantation With Core Antibody Positive Grafts: The Role of Surface Antibody Status in Guiding Long\u2010Term Prophylaxis","volume":"38","author":"Busebee B.","year":"2024","journal-title":"Clinical Transplantation"},{"issue":"1","key":"e_1_2_8_136_1","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14305","article-title":"Hepatitis B Transmission\/Reactivation Associated With Hepatitis B Core Antibody and Hepatitis C Nucleic Acid Testing Positive Organs: A Report From the Organ Procurement and Transplantation Network Disease Transmission Advisory Committee","volume":"26","author":"Te H. S.","year":"2024","journal-title":"Transplant Infectious Disease: An Official Journal of the Transplantation Society"},{"issue":"8","key":"e_1_2_8_137_1","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1016\/j.ajt.2025.07.313","article-title":"Donor\u2010Derived Hepatitis B Virus (HBV) Infection in Solid Organ Transplant (SOT) Recipients: Report from the Organ Procurement & Transplantation Network Ad Hoc Disease Transmission Advisory Committee (OPTN DTAC)","volume":"25","author":"Fisher C.","year":"2025","journal-title":"American Journal of Transplantation"},{"key":"e_1_2_8_138_1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001549"},{"issue":"6","key":"e_1_2_8_139_1","first-page":"605","article-title":"Transplanting Kidneys From Donors With Prior Hepatitis B Infection: One Response to the Organ Shortage","volume":"15","author":"Fabrizio F.","year":"2002","journal-title":"Journal of Nephrology"},{"issue":"3","key":"e_1_2_8_140_1","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00007890-199708150-00011","article-title":"Risks of Transplanting Kidneys From Hepatitis B Surface Antigen\u2010Negative, Hepatitis B Core Antibody\u2010Positive Donors","volume":"64","author":"Satterthwaite R.","year":"1997","journal-title":"Transplantation"},{"issue":"5","key":"e_1_2_8_141_1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1399-3062.2012.00782.x","article-title":"Renal Grafts From Anti\u2010Hepatitis B Core\u2010Positive Donors: A Quantitative Review of the Literature","volume":"14","author":"Mahboobi N.","year":"2012","journal-title":"Transplant Infectious Disease: An Official Journal of the Transplantation Society"},{"issue":"2","key":"e_1_2_8_142_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.trre.2024.100840","article-title":"Was Antiviral Prophylaxis Necessary After Kidney Transplantation Utilizing HBcAb+ Donors? A Systematic Review and Meta\u2010Analysis","volume":"38","author":"Yin S.","year":"2024","journal-title":"Transplantation Reviews"},{"issue":"5","key":"e_1_2_8_143_1","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/tid.12280","article-title":"Hepatitis B Core Antibody\u2010Positive Donors in Cardiac Transplantation: A Single\u2010Center Experience","volume":"16","author":"Horan J. L.","year":"2014","journal-title":"Transplant Infectious Disease: An Official Journal of the Transplantation Society"},{"issue":"2","key":"e_1_2_8_144_1","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.transproceed.2004.12.041","article-title":"Risk of Transmission of Hepatitis B Virus From Anti\u2010HBC Positive Cadaveric Organ Donors: A Collaborative Study","volume":"37","author":"De Feo T. M.","year":"2005","journal-title":"Transplantation Proceedings"},{"issue":"1","key":"e_1_2_8_145_1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0041-1345(01)02666-5","article-title":"Is There Any Risk of Transmission of Hepatitis B From Heart Donors Hepatitis B Core Antibody Positive?","volume":"34","author":"Blanes M.","year":"2002","journal-title":"Transplantation Proceedings"},{"issue":"10","key":"e_1_2_8_146_1","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1016\/j.transproceed.2005.11.025","article-title":"Frequent Detection of Hepatitis B Core Antibodies in Heart Transplant Recipients Without Preceding Hepatitis B Infection","volume":"37","author":"Tenderich G.","year":"2005","journal-title":"Transplantation Proceedings"},{"issue":"6","key":"e_1_2_8_147_1","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/TP.0b013e3181b4e1fd","article-title":"Impact of Hepatitis B Core Antibody Positive Donors in Lung and Heart\u2010Lung Transplantation: An Analysis of the United Network For Organ Sharing Database","volume":"88","author":"Dhillon G. S.","year":"2009","journal-title":"Transplantation"},{"issue":"3","key":"e_1_2_8_148_1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/01.tp.0000165858.86067.a2","article-title":"Hepatitis B Core Antibody Positive Donors as a Safe and Effective Therapeutic Option to Increase Available Organs for Lung Transplantation","volume":"80","author":"Hartwig M. G.","year":"2005","journal-title":"Transplantation"},{"issue":"5","key":"e_1_2_8_149_1","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/01.tp.0000198585.51562.57","article-title":"Anti\u2010HBc Seroconversion After Transplantation of Anti\u2010HBc Positive Nonliver Organs to Anti\u2010HBc Negative Recipients","volume":"81","author":"Fytili P.","year":"2006","journal-title":"Transplantation"},{"issue":"3","key":"e_1_2_8_150_1","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000763","article-title":"Transplantation of a Liver Allograft From a Hepatitis C Virus Seropositive Donor With Previous Sustained Virologic Response to an Uninfected Recipient Suffering Steroid Refractory Acute Graft Rejection With No Evidence of HCV Transmission","volume":"4","author":"Mitchell R. A.","year":"2018","journal-title":"Transplantation Direct"},{"issue":"4","key":"e_1_2_8_151_1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jhep.2014.05.003","article-title":"Safe Use of Liver Grafts From Hepatitis B Surface Antigen Positive Donors in Liver Transplantation","volume":"61","author":"Yu S.","year":"2014","journal-title":"Journal of Hepatology"},{"issue":"1","key":"e_1_2_8_152_1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/lt.26543","article-title":"Use and Outcomes of Hepatitis B Virus\u2010Positive Grafts in Orthotopic Liver Transplantation in the United States from 1999 to 2021","volume":"29","author":"Ali S. E.","year":"2023","journal-title":"Liver Transplantation"},{"issue":"8","key":"e_1_2_8_153_1","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.ajt.2023.04.024","article-title":"Transplanting Hepatitis B Surface Antigen\u2010Positive Livers in the United States: Outcomes and Opportunities","volume":"23","author":"Bhatnagar A.","year":"2023","journal-title":"American Journal of Transplantation"},{"issue":"1","key":"e_1_2_8_154_1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/lt.23774","article-title":"Use of Hepatitis B Surface Antigen\u2010Positive Grafts in Liver Transplantation: A Matched Analysis of the US National Database","volume":"20","author":"Li Z.","year":"2014","journal-title":"Liver Transplantation"},{"issue":"7","key":"e_1_2_8_155_1","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/LVT.0000000000000533","article-title":"Outcomes Following the Use of HBsAg\u2010Positive Liver Allografts in HBsAg\u2010Negative Recipients","volume":"31","author":"Myer A. S.","year":"2025","journal-title":"Liver Transplantation"},{"issue":"4","key":"e_1_2_8_156_1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/XCS.0000000000001288","article-title":"Friend or Foe? Safety and Efficacy of Hepatitis B Viremic Solid Organ Allograft into Seronegative Recipients","volume":"240","author":"Pratt C. G.","year":"2025","journal-title":"Journal of the American College of Surgeons"},{"issue":"4","key":"e_1_2_8_157_1","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/SLA.0000000000005071","article-title":"Expanding the Donor Pool: First Use of Hepatitis B Virus Nat Positive Solid Organ Allografts Into Seronegative Recipients","volume":"274","author":"Delman A. M.","year":"2021","journal-title":"Annals of Surgery"},{"issue":"3","key":"e_1_2_8_158_1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jhep.2020.04.008","article-title":"The Global Prevalence of Hepatitis D Virus Infection: Systematic Review and Meta\u2010Analysis","volume":"73","author":"Stockdale A. J.","year":"2020","journal-title":"Journal of Hepatology"},{"issue":"12","key":"e_1_2_8_159_1","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1111\/ajt.12921","article-title":"The Outcomes of Kidney Transplantation in Hepatitis B Surface Antigen (HBsAg)\u2010Negative Recipients Receiving Graft from HBsAg\u2010Positive Donors: A Retrospective, Propensity Score\u2010Matched Study","volume":"14","author":"Chancharoenthana W.","year":"2014","journal-title":"American Journal of Transplantation"},{"issue":"11","key":"e_1_2_8_160_1","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1111\/liv.15703","article-title":"Expanding the Donor Pool: Kidney Transplantation From Serum HBV DNA or HBeAg\u2010Positive Donors to HBsAg\u2010Negative Recipients","volume":"43","author":"Yin S.","year":"2023","journal-title":"Liver International"},{"issue":"3","key":"e_1_2_8_161_1","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14295","article-title":"Utilization of Hepatitis B Viremic Donors (NAT+) Leads to Improved Kidney Transplant Access for Older Adult Recipients with Little to No Wait Time","volume":"26","author":"Lopez\u2010Soler R. I.","year":"2024","journal-title":"Transplant Infectious Disease: An Official Journal of the Transplantation Society"},{"issue":"2","key":"e_1_2_8_162_1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.23876\/j.krcp.23.233","article-title":"The Impact of Donor Hepatitis B Virus Infection on Transplant Outcomes in Deceased Donor Kidney Transplantation Recipients","volume":"44","author":"Luo Y.","year":"2025","journal-title":"Kidney Research and Clinical Practice"},{"issue":"3","key":"e_1_2_8_163_1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/TP.0000000000004759","article-title":"Use and Outcomes of Hepatitis B Virus\u2010Positive Grafts for Kidney or Heart Transplantation in the United States From 1999 to 2021","volume":"108","author":"Singal A. K.","year":"2024","journal-title":"Transplantation"},{"issue":"5","key":"e_1_2_8_164_1","doi-asserted-by":"crossref","DOI":"10.1111\/tid.70054","article-title":"Hepatitis B Virus Donor Positive to Recipient Negative (D+\/R\u2010) Heart and Lung Transplantation: Analysis From the Organ Procurement and Transplantation Network","volume":"27","author":"Belga S.","year":"2025","journal-title":"Transplant Infectious Disease: An Official Journal of the Transplantation Society"},{"issue":"10","key":"e_1_2_8_165_1","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2023-255663","article-title":"Living\u2010Donor Lobar Lung Transplantation From a Hepatitis B Surface Antigen\u2010Positive Donor to a Negative Recipient","volume":"16","author":"Yamaya T.","year":"2023","journal-title":"BMJ Case Reports"},{"issue":"8","key":"e_1_2_8_166_1","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/j.transproceed.2004.08.112","article-title":"Heart Transplantation Using Donors Positive for Hepatitis","volume":"36","author":"Wang S. S.","year":"2004","journal-title":"Transplantation Proceedings"},{"issue":"4","key":"e_1_2_8_167_1","doi-asserted-by":"crossref","DOI":"10.1111\/tid.70013","article-title":"Lessons From the Utilization of Hepatitis B Virus Nucleic Acid Test Positive Donors for Hepatitis B Vaccinated Lung Transplant Candidates (INHIBITOR) Study","volume":"27","author":"Courtwright A. M.","year":"2025","journal-title":"Transplant Infectious Disease: An Official Journal of the Transplantation Society"},{"issue":"17","key":"e_1_2_8_168_1","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa1812406","article-title":"Heart and Lung Transplants from HCV\u2010Infected Donors to Uninfected Recipients","volume":"380","author":"Woolley A. E.","year":"2019","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"e_1_2_8_169_1","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.transproceed.2012.04.015","article-title":"Hepatitis B Surface Antigen Positivity is Not a Contraindication for Living Kidney Donation","volume":"44","author":"Tuncer M.","year":"2012","journal-title":"Transplantation Proceedings"},{"issue":"2","key":"e_1_2_8_170_1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","article-title":"Update of the Statements on Biology and Clinical Impact of Occult Hepatitis B Virus Infection","volume":"71","author":"Raimondo G.","year":"2019","journal-title":"Journal of Hepatology"},{"issue":"1","key":"e_1_2_8_171_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-79392-x","article-title":"Occult Hepatitis B Virus Infection Among HIV Negative and Positive Isolated Anti\u2010HBc Individuals in Eastern Ethiopia","volume":"10","author":"Ayana D. A.","year":"2020","journal-title":"Scientific Reports"},{"issue":"3","key":"e_1_2_8_172_1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MOT.0000000000000766","article-title":"Lung Transplant Programs in Developing Countries: Challenges, Solutions, and Outcomes","volume":"25","author":"Nguyen A. T.","year":"2020","journal-title":"Current Opinion in Organ Transplantation"},{"issue":"5","key":"e_1_2_8_173_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41591-025-03653-3","article-title":"Effect of Felzartamab on the Molecular Phenotype of Antibody\u2010Mediated Rejection in Kidney Transplant Biopsies","volume":"31","author":"Diebold M.","year":"2025","journal-title":"Nature Medicine"},{"issue":"6","key":"e_1_2_8_174_1","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2021.11.024","article-title":"How to Achieve Functional Cure of HBV: Stopping NUCs, Adding Interferon or New Drug Development?","volume":"76","author":"Wong G. L.","year":"2022","journal-title":"Journal of Hepatology"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.70299","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/tid.70299","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.70299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:14:30Z","timestamp":1787753670000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.70299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":173,"alternative-id":["10.1111\/tid.70299"],"URL":"https:\/\/doi.org\/10.1111\/tid.70299","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]},"assertion":[{"value":"2026-02-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70299"}}